| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3e182c0c7bc69e566750a7c5d0bdda |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6765f8795df875e7ad510dfc0a3912bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b3725b78f85fe5c2e895a50e753067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7242db50ad752d9bf2454b872008eac |
| publicationDate |
2019-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3505157-A1 |
| titleOfInvention |
Dry powder ketamine composition for pulmonary administration in treatment-resistant depression |
| abstract |
A dry powder pharmaceutical composition comprising ketamine or its pharmaceutically acceptable salt for use in a medicine adapted for administration via pulmonary route. The composition is especially useful for the treatment of treatment-resistant or treatment-refractory depression. |
| priorityDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |